Biotech Values

[DewDiligence]

>MNTA – Would there be any rationale for thinking that the M118 trial would be affected by today's heparin problem? (Heparin in the control arm)<

I doubt it. The patients in the M118 trial have stable angina and are scheduled to undergo PCI, which is considered an elective procedure. There ought to be ample time for these patients to receive a slow infusion of heparin rather than the bolus administration that has been linked to allergic reactions.